Regeneron Genetics Center Fully Operational, Announces New Collaborations And Key Appointments

By: via Benzinga
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Regeneron Genetics Center LLC (RGC), a wholly-owned subsidiary, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.